Navigation Links
Generics and Biosimilars in Central and Eastern Europe 25-26 June - Warsaw, Poland
Date:4/4/2013

LONDON, April 4, 2013 /PRNewswire/ --

Having shown steady recovery from the global economic crisis, the CEE region continues to gain investment from foreign market players, quite a few of which have already successfully established their business in the region. Local market players like Polpharma, Gedeon Richter , Krka, Zentiva and Lek (recently acquired by the Novartis Group), have an impressively strong position within the entire CEE region, becoming a growing subject of interest for the Multinationals and their portfolio ambitions.

With this in mind, CPhI Conferences, in partnership with Polpharma, is proud to present its inaugural conference on Generics and Biosimilars in Central and Eastern Europe which has been designed to assess regulatory hurdles, share best practice and highlight ample market opportunities.

We are delighted to be joined by high-quality industry professionals including IMS Health, MHRA, Janssen Pharmaceuticals, Egis, Polpharma, Selvita and many more. With expert speakers in generic and biosimilar development across the merging markets of CEE, this conference offers the opportunity to network and debate with leaders in this field.

Over the course of two intensive days there will be practical and informative sessions on the current and future market trends, innovation strategies in generic and biosimilar development, identifying the crucial factors in successful partnerships, commercialisation and market access. This is an essential opportunity to gather the information you need to advance your business strategy and establish yourself in this lucrative market.


For the full programme including a list of the expert speakers and to register please visit http://www.cphi-cee.com

About CPhI Conferences:

CPhI Conferences deliver the latest pharma market insight, in-depth case studies and exceptional networking opportunities through a programme of high-level conferences. The worldwide series of events, spanning four continents, provides the optimum forum for you to learn, make new business connections and identify the latest growth opportunities. Delivered by expert teams in each region, every conference is extensively researched with leading professionals, ensuring that CPhI Conferences tackle the most business critical issues facing the pharma industry today.

http://www.cphiconferences.com

For further information, please contact:

Svetlana Fathers
Senior Conference Producer
CPhI Conferences
Tel: +44(0)20-7955-3973
E-mail: svetlana.fathers@ubm.com


'/>"/>
SOURCE CPhI Conferences
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Managing Bioequivalence Studies to Optimize Cost, Quality, and Outsourcing of Generics Manufacturing
2. Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
3. Watson Announces Global Generics Management Team
4. Generics Analysis: Key Patent Case Reviews
5. Branded Generics in South East Asia: Current and Future Opportunities
6. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
7. Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth
8. Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
9. Lupus Foundation of Florida Applauds Support for Biosimilars Legislation
10. Two New Strategic Reports Expand Coverage Of BioTrends Biosimilars Advisory Service
11. Global Biosimilars Market - Products, Applications and Regulations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
Breaking Medicine News(10 mins):